Xigduo® XR (dapagliflozin/metformin) – First-time authorized brand alternative

Dynamic Alerts

Site Logo

Health care professionals website

DPL Global Search

DPL Main Nav

DPL Global Search

Breadcrumbs

Text

Xigduo^® XR (dapagliflozin/metformin) – First-time authorized brand alternative

January 3, 2024 - Prasco launched an authorized brand alternative of AstraZeneca’s Xigduo XR (dapagliflozin/metformin) extended-release tablets.

Text

Return to publications

Top